Identification of Markers Associated With Development of Stroke in “Clinically Low‐Risk” Atrial Fibrillation Patients

Background Stroke and thromboembolic events may still occur in “clinically low‐risk” atrial fibrillation ( AF ) patients as categorized by CHA 2 DS 2 ‐ VAS c score. Our aim was to assess the proportion of “clinically low‐risk” patients using a nongender CHA 2 DS 2 ‐ VAS c (ie, CHA 2 DS 2 ‐ VA ) score of 0 to 1 among patients who experienced AF ‐associated stroke and to identify markers associated with stroke in “clinically low‐risk” patients....